The mainboard initial public offering (IPO) of New Delhi/Gurugram-headquartered pediatric neurodevelopmental therapy, developmental care centres, and special education healthcare specialist Rays of Be…
The mainboard initial public offering (IPO) of New Delhi/Gurugram-headquartered pediatric neurodevelopmental therapy, developmental care centres, and special education healthcare specialist Rays of Belief Limited (operating under the flagship brand Mom’s Belief) concluded its multi-day book-building bidding window across national bourses today, Thursday, September 3, 2026.
Following an aggressive ramp-up across Day 1 (1.18x) and Day 2 (3.61x), the third and final trading session witnessed a massive wave of retail capital, high-net-worth wealth accounts, and late institutional participation. By the close of bidding at 5:00 PM IST across BSE and NSE, central exchange matching registries compiled valid electronic application tokens for 33,72,18,434 equity shares against a net public offer pool of 31,37,810 equity shares (excluding anchor allocations).
This propelled the final cumulative subscription baseline to an extraordinary 107.47 times (10,747% coverage).
Non-Institutional Investors (NII / HNI) and retail individual investors led the final surge well past the century milestone, taking their respective quotas to 279.04 times and 194.52 times, while Qualified Institutional Buyers (QIBs) stepped up bids during the final afternoon to close at 9.06 times.
Priced within an official price band parameter of ₹227.00 to ₹239.00 per share with an aggregate capital issue size of ₹125.00 crore, the public offering mobilized an aggregate primary capital demand value of ₹8,059.52 crore (~₹8.06 Thousand Crore) clearing through central registries (calculated at the upper price band cap of ₹239 per share).
With public bidding officially locked, market attention shifts directly to final allotment probabilities, unlisted grey market trends, the rollout of 319 new therapy centres across India, and the upcoming stock exchange debut scheduled for Tuesday, September 8, 2026.
Here is an extended, plain-English breakdown covering final subscription metrics, unlisted grey market trends, business operations across neurodevelopmental disorder (NDD) therapies, financial performance, capex deployment plans, valuation parameters, and the step-by-step allotment guide.
1. Final Subscription Data Breakdown
By 5:00 PM on the final day, central exchange processing registries compiled total valid application orders worth ₹8,059.52 crore (calculated at the upper price band cap of ₹239 per share), covering 10,747% of the net public offer.
The table below summarizes the closing performance across all investor categories:
+-----------------------------------------------------------------------------------+ | RAYS OF BELIEF LIMITED: FINAL SUBSCRIPTION DATA | +-------------------+-----------------+------------------+------------------+-------+ | Category | Shares Offered | Shares Bid For | Final Sub (x) | Value | +-------------------+-----------------+------------------+------------------+-------+ | QIB (Institutions)| 18,30,310 | 1,65,76,630 | 9.06x | ₹396.18Cr | NII / HNI (Wealth)| 7,84,500 | 21,89,06,252 | 279.04x | ₹5,231.86Cr | Retail (RII) | 5,23,000 | 10,17,35,552 | 194.52x | ₹2,431.48Cr +-------------------+-----------------+------------------+------------------+-------+ | Total Net Offer | 31,37,810 | 33,72,18,434 | 107.47x | ₹8,059.52Cr +-------------------+-----------------+------------------+------------------+-------+
(Source: BSE/NSE Consolidated Bidding Platform Data)
Analyzing the Final Category Inflows:
- Non-Institutional Investors (NII / HNI - 279.04x): High-net-worth wealth accounts, corporate treasuries, and family offices posted the highest category oversubscription rate, rocketing from 16.19 lakh shares (2.06x) on Day 2 to 21,89,06,252 shares worth ₹5,231.86 crore against 7.85 lakh shares offered, closing at 279.04 times. Both small-HNI (sNII) and big-HNI (bNII) brackets saw massive multi-lot participation.
- Retail Individual Investors (RII - 194.52x): Everyday retail accounts expanded their bids to reach 10,17,35,552 shares (16,40,896 application lots) worth ₹2,431.48 crore against 5.23 lakh shares reserved for them, pushing retail coverage to a staggering 194.52 times. The minimum retail application lot was fixed at 62 shares, requiring an upfront layout of ₹14,818 at ₹239 per share.
- Qualified Institutional Buyers (QIB - 9.06x): Institutional desks stepped up activity during the final hours, jumping from 14,942 shares on Day 2 to 1,65,76,630 shares worth ₹396.18 crore against 18.30 lakh shares offered in their net allocation slice, closing institutional coverage at 9.06 times.
- Anchor Investor Allocation: Prior to the public open, Rays of Belief raised ₹50.00 crore through its institutional anchor placement on Monday, August 31, 2026, allocating 20,92,190 equity shares at ₹239 per share to 5 marquee institutional anchor investors.
2. Unlisted Grey Market Premium (GMP) & Expected Listing Gains
With final bidding figures locking in above the 100x milestone, sentiment in the unlisted grey market corridors has strengthened:
- Fixed Upper Price Cap Anchor: ₹239.00 per share
- Current Grey Market Premium (GMP): Tracking around +₹45.00 to +₹55.00 per share (~18.8% to 23.0% over issue price)
- Estimated Listing Price Range: Expected debut counter level of ₹284.00 to ₹294.00 per share
- Projected Listing Gain Margin: Indicating an immediate estimated listing upside of ~18.83% to 23.01%
- Retail Application Lot Size: 62 Shares (Minimum Investment: ₹14,818)
What Is Driving Grey Market Optimism?
- Niche Healthcare Moat (Mom’s Belief): Operating India's largest organized pediatric developmental care network for children diagnosed with Autism Spectrum Disorder (ASD), ADHD, Down Syndrome, and learning delays, spanning 136 centres across 57 cities and 20 states/UTs alongside 3 US centres.
- Aggressive Expansion & Balance Sheet Recapitalization: 100% fresh issue proceeds fund the physical rollout of 319 new therapy centres across India, clinic hardware, and technology tools, backed by low debt-to-equity (0.12x).
(Note: Grey market premiums represent informal, off-exchange quotes traded among dealers. They fluctuate based on daily market mood and should not be treated as a guaranteed listing price.)
3. Business Overview: What Does Rays of Belief Do?
Incorporated in 2017 and operating under the widely recognized brand Mom’s Belief, Rays of Belief Limited is an integrated social enterprise and specialized pediatric developmental healthcare provider.
The company delivers personalized clinical and behavioral intervention programs for children aged 18 months to 15 years diagnosed with Neurodevelopmental Disorders (NDDs).
The company's core service suite includes:
- Multidisciplinary Clinical Therapies: Occupational therapy, speech and language pathology, sensory integration, physical therapy, and behavioral interventions.
- Centres Network & Collaboration Models: Company-Owned Learning Centres, Licensed Professional Partnership Centres (partnering with pediatricians and child psychologists), and School Collaboration Centres.
- Digital & Home-Learning Ecosystem: Proprietary child tracking software, over 150 clinic teaching tools, and 2,000+ customized home-learning therapy kits.
- Global Footprint: 136 operational centres across India and 3 wholly-owned international therapy centres in Virginia, USA (Mom's Belief US, Inc.).
+-----------------------------------------------------------------------------------+ | RAYS OF BELIEF BUSINESS AT A GLANCE | +-------------------+---------------------------------------------------------------+ | Core Brand Platform | Mom's Belief (Pediatric Developmental Care) | +-----------------------------------+-----------------------------------------------+ | Specialization | Autism (ASD), ADHD, Speech Delay, Down Syn. | +-----------------------------------+-----------------------------------------------+ | Active Centre Network | 136 Centres Across 57 Indian Cities + 3 in USA| +-----------------------------------+-----------------------------------------------+ | Clinical Workforce | 340+ Certified Clinical Professionals | +-----------------------------------+-----------------------------------------------+ | Children Impacted | Upwards of 58,000+ Children Since Inception | +-----------------------------------+-----------------------------------------------+ | Lead Manager (BRLM) | Mefcom Capital Markets Limited | +-----------------------------------+-----------------------------------------------+ | Registrar to the Issue | KFin Technologies Limited | +-----------------------------------+-----------------------------------------------+
(Source: Company Red Herring Prospectus)
Core Competitive Moats:
1. First-Mover Advantage in Organized NDD Healthcare
The Indian pediatric developmental therapy market remains highly unorganized. Mom's Belief is the largest institutional chain providing standardized clinical protocols, multi-therapy integration, and parent coaching under one roof.
2. Asset-Light Partnership Expansion Model
By partnering with independent clinics, child psychologists, and schools, the company expands its physical footprint across Tier-2 and Tier-3 cities with minimal upfront real estate capex.
3. 100% Fresh Issue Primary Rollout
Allocating IPO capital directly into 319 new centre fit-outs, clinic hardware, and therapy technology provides visibility for multi-year revenue compounding.
4. Detailed Financial Performance (FY24 to FY26)
An audit of the company's restated financial statements shows rapid revenue expansion and sustained operational profitability over the last three fiscal years.
+-----------------------------------------------------------------------------------+ | RAYS OF BELIEF: 3-YEAR FINANCIAL PERFORMANCE | +-------------------------------+-------------------+-------------------+-----------+ | Financial Metric (₹ in Cr) | FY24 | FY25 | FY26 | +-------------------------------+-------------------+-------------------+-----------+ | Revenue from Operations | 30.61 | 36.42 | 81.66 | | Total Income | 30.76 | 36.54 | 82.06 | | Operating EBITDA | 1.49 | 3.02 | 11.91 | | EBITDA Margin (%) | 4.87% | 8.28% | 14.59% | | Net Profit After Tax (PAT) | 0.85 | 5.88 | 4.96 | | PAT Margin (%) | 2.79% | 16.15% | 6.07% | | Net Worth | 5.78 | 15.02 | 23.76 | | Return on Equity (ROE %) | 16.83% | 56.56% | 21.64% | | Return on Capital Employed % | N/A | 7.49% | 29.74% | | Debt-to-Equity Ratio (x) | N/A | 0.29x | 0.12x | +-------------------------------+-------------------+-------------------+-----------+
(Source: Restated Financial Statements in Prospectus & KPI Reports)
Key Financial Observations:
- Massive Revenue Scaling (167% 2-Year Growth): Total income expanded from ₹30.76 crore in FY24 to ₹36.54 crore in FY25, before jumping 124.6% YoY to ₹82.06 crore in FY26, driven by new centre additions and strong therapy session demand.
- Expanding Operating EBITDA (~14.6%): Operating EBITDA grew to ₹11.91 crore in FY26 (an eightfold expansion over FY24's ₹1.49 crore), with EBITDA margins reaching 14.59% due to higher clinical utilization per centre.
- Consistent Profitability: Net profit after tax (PAT) stood at ₹4.96 crore in FY26 (delivering a 6.07% PAT margin), while FY25 PAT included deferred tax adjustments.
- Improving Capital Efficiency & Low Leverage: The company delivered a Return on Capital Employed (ROCE) of 29.74% and an ROE of 21.64% in FY26, operating with a very low debt-to-equity ratio of 0.12x.
5. Structure of the Offer & Objects of the Issue
The ₹125.00 crore public issue is structured entirely as a fresh primary capital issuance:
+-----------------------------------------------------------------------------------+ | IPO CAPITAL STRUCTURE BREAKDOWN | +-----------------------------------+-----------------------------------------------+ | Total Issue Size | ₹125.00 Crore (52,30,000 Equity Shares) | +-----------------------------------+-----------------------------------------------+ | Fresh Issue Component | ₹125.00 Crore (100% Fresh Capital Issue) | +-----------------------------------+-----------------------------------------------+ | Offer for Sale (OFS) Component | ₹0.00 (No Selling Shareholders) | +-----------------------------------+-----------------------------------------------+ | Price Band | ₹227.00 to ₹239.00 per share | +-----------------------------------+-----------------------------------------------+ | Face Value | ₹10 per share | +-----------------------------------+-----------------------------------------------+ | Anchor Investor Allocation | 20,92,190 Shares (₹50.00 Crore Value) | +-----------------------------------+-----------------------------------------------+ | Net Offer to Public | 31,37,810 Shares (₹75.00 Crore Value) | +-----------------------------------+-----------------------------------------------+ | Lead Manager (BRLM) | Mefcom Capital Markets Limited | +-----------------------------------+-----------------------------------------------+ | Registrar to the Issue | KFin Technologies Limited | +-----------------------------------+-----------------------------------------------+
(Source: Official Red Herring Prospectus)
How Will Fresh Primary Capital Be Deployed?
Because there is no Offer for Sale (OFS), 100% of the proceeds move directly onto the company balance sheet:
- Establishment of New Therapy Centres (₹41.36 Crore / 33.1%): Funding the rollout, fit-outs, and technology hardware for 319 new therapy and developmental centres across India.
- Lease Payments for Existing Indian Centres (₹14.45 Crore / 11.6%): Meeting operational lease obligations across its domestic centre network.
- Investment in US Subsidiary (₹10.13 Crore / 8.1%): Funding lease and operational expansion for Mom's Belief US, Inc. in Virginia.
- General Corporate Purposes & Issue Expenses (₹59.06 Crore / 47.2%): Supporting brand marketing, clinical software development, and working capital needs.
6. Valuation Analysis & Peer Group Comparison
At the upper price band cap of ₹239 per share, Rays of Belief commands a post-issue corporate market capitalization of approximately ₹499.55 crore (based on post-issue equity share capital of 2,09,01,682 shares).
Because there are no directly comparable pure-play listed neurodevelopmental healthcare therapy chains in India, we evaluate the company alongside listed specialized healthcare service providers and hospital chains:
+-----------------------------------------------------------------------------------+ | PEER GROUP VALUATION COMPARISON | +-----------------------------------+--------------------+--------------------------+ | Company Name | Trailing P/E (x) | Primary Focus / Model | +-----------------------------------+--------------------+--------------------------+ | Rays of Belief (At ₹239) | ~100.7x (Post-IPO) | Pediatric NDD Therapy | | Rainbow Children's Medicare Ltd | ~56.40x | Pediatric & Maternity | | Aster DM Healthcare Ltd | ~48.20x | Multi-Specialty Hospital | | KIMS Hospitals Ltd | ~52.80x | Tertiary Care Hospitals | | Yatharth Hospital Ltd | ~38.60x | Multi-Specialty Hospital | +-----------------------------------+--------------------+--------------------------+
Valuation Summary:
At ~100.7x post-issue FY26 trailing earnings (and ~6.1x Price-to-Sales), Rays of Belief was priced at a growth-stage premium reflecting its unique position as India's premier organized developmental therapy platform.
With 124%+ top-line growth in FY26, high ROE (21.64%), near-zero debt (0.12x D/E), and ₹125 crore deployed directly into expanding the physical clinic network from 136 to over 450+ centres, the unique social impact and healthcare growth story catalyzed the massive 107.47x final oversubscription and solid grey market premium (+₹45–₹55).
7. Core Strengths vs. Key Business Risks
Investors evaluating this mainboard pediatric healthcare issue should consider the following operational factors:
Key Strengths:
- Blockbuster Final Subscription (107.47x): Total primary demand breached ₹8,059 crore with HNIs at 279.04x, Retail at 194.52x, and QIBs at 9.06x.
- 100% Fresh Issue Deployment: ₹125 crore fresh equity directly funds opening 319 new therapy centres and scaling technology.
- Niche Category Leader: Operates Mom's Belief, the largest organized network for Autism, ADHD, and pediatric developmental delays in India.
- Asset-Light & Low Debt: Operates with a minimal debt-to-equity ratio of 0.12x and an ROCE of 29.74%.
Key Risk Factors:
- Premium Growth Valuation: Priced at ~100.7x FY26 trailing P/E, requiring execution on its aggressive 319-centre expansion roadmap.
- Talent Dependency: Scalability relies heavily on hiring, training, and retaining qualified speech therapists, occupational therapists, and clinical psychologists.
- Negative Operating Cash Flow: Reported negative operating cash flows in FY26 due to aggressive centre rollout and inventory build-up.
8. Application Matrix & Final Listing Timeline
With the public offer now closed, here is the upcoming schedule for allotment finalization and listing:
- Public Bidding Window Closes: Thursday, September 3, 2026 (Status: Bidding Closed)
- Basis of Allotment Finalization: Friday, September 4, 2026
- Refund Initiations & Unblocking of Bank Funds: Monday, September 7, 2026
- Credit of Equity Shares to Demat Accounts: Monday, September 7, 2026
- Official Stock Exchange Listing (BSE & NSE): Tuesday, September 8, 2026
- Designated Lead Manager: Mefcom Capital Markets Limited
- Designated Registrar: KFin Technologies Limited
How to Check Your Allotment Status:
When allotment details go live on Friday, September 4, 2026, applicants can check their status by entering their PAN card number or Application ID on the KFin Technologies Portal or directly on the official BSE/NSE websites under the issue allotment sections.
Conclusion
Rays of Belief has concluded its public offering with a massive century-plus 107.47x overall subscription (~₹8,059.52 crore total primary demand), propelled by 279.04x HNI bidding, 194.52x retail coverage, and 9.06x QIB participation.
With Mom's Belief brand equity, 136 active centres, ₹82+ crore in revenue scale, ₹4.96 crore reported PAT, near-zero debt (0.12x D/E), and ₹125 crore fresh capital dedicated to opening 319 new therapy centres, the company is set for its mainboard debut on BSE and NSE on Tuesday, September 8.
Post Excerpt
A complete final day analysis of the ₹125.00 crore Rays of Belief Ltd (Mom's Belief) IPO. Total subscription closed at a massive 107.47x, led by 279.04x in HNIs, 194.52x in retail, and 9.06x in QIBs as total primary demand crossed ₹8,059 crore. Read our full review of company financials (₹82+ Cr revenue, ₹4.96 Cr PAT), Autism and ADHD developmental therapy moats, grey market trends (+₹45–₹55), allotment schedule, and valuation (100.7x post-issue P/E) ahead of its September 8 listing.
